6 results on '"Eichenauer, Dennis Alexander"'
Search Results
2. Airway Pressure Release Ventilation in COVID-19-Associated Acute Respiratory Distress Syndrome—A Multicenter Propensity Score–Matched Analysis.
- Author
-
Naendrup, Jan-Hendrik, Steinke, Jonathan, Garcia Borrega, Jorge, Stoll, Sandra Emily, Michelsen, Per Ole, Assion, Yannick, Shimabukuro-Vornhagen, Alexander, Eichenauer, Dennis Alexander, Kochanek, Matthias, and Böll, Boris
- Subjects
ADULT respiratory distress syndrome ,COVID-19 ,VENTILATION ,INTENSIVE care units ,CRITICAL care medicine - Abstract
Background: There are limited and partially contradictory data on the effects of airway pressure release ventilation (APRV) in COVID-19-associated acute respiratory distress syndrome (CARDS). Therefore, we analyzed the clinical outcome, complications, and longitudinal course of ventilation parameters and laboratory values in patients with CARDS, who were mechanically ventilated using APRV. Methods: Respective data from 4 intensive care units (ICUs) were collected and compared to a matched cohort of patients receiving conventional low tidal volume ventilation (LTV). Propensity score matching was performed based on age, sex, blood gas analysis, and APACHE II score at admission, as well as the implementation of prone positioning. Findings: Forty patients with CARDS, who were mechanically ventilated using APRV, and 40 patients receiving LTV were matched. No significant differences were detected for tidal volumes per predicted body weight, peak pressure values, and blood gas analyses on admission, 6 h post admission as well as on day 3 and day 7. Regarding ICU survival, no significant difference was identified between APRV patients (40%) and LTV patients (42%). Median duration of mechanical ventilation and duration of ICU treatment were comparable in both groups. Similar complication rates with respect to ventilator-associated pneumonia, septic shock, thromboembolic events, barotrauma, as well as the necessity for hemodialysis were detected for both groups. Clinical characteristics that were associated with increased mortality in a Cox proportional hazards regression analysis included age (hazard ratio [HR] 1.08, 95% confidence interval [CI] 1.04-1.1; P <.001), severe acute respiratory distress syndrome (HR 2.62, 95% CI 1.02-6.7; P =.046) and the occurrence of septic shock (HR 17.18, 95% CI 2.06-143.2; P =.009), but not the ventilation mode. Interpretation: Intensive care unit survival, duration of mechanical ventilation, and ICU treatment as well as ventilation-associated complication rates were equivalent using APRV compared to conventional LTV in patients with CARDS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Reactivation of EBV and CMV in Severe COVID-19--Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients.
- Author
-
Naendrup, Jan-Hendrik, Garcia Borrega, Jorge, Eichenauer, Dennis Alexander, Shimabukuro-Vornhagen, Alexander, Kochanek, Matthias, and Böll, Boris
- Subjects
EPSTEIN-Barr virus ,CYTOMEGALOVIRUSES ,CORONAVIRUS diseases ,INTENSIVE care units ,SARS disease ,CRITICALLY ill - Abstract
Background: Reactivation of viruses such as Epstein-Barr virus (EBV) and cytomegalovirus (CMV) are common in critically ill patients and have been described in patients with severe COVID-19. However, it is unclear whether these reactivations are associated with increased mortality and whether targeted treatments are beneficial. Methods: In a retrospective single-center cohort study, patients with severe COVID-19 treated on our intensive care unit (ICU) were screened for EBV and CMV reactivation as detected by polymerase chain reaction. If present, patient characteristics, temporal connections to severe acute respiratory syndrome coronavirus 2 diagnosis and corticosteroid use, the use of targeted treatments as well as the course of disease and outcome were analyzed. As control group, non-COVID-19 patients with sepsis, treated within the same time period on our ICU, served as control group to compare incidences of viral reactivation. Results: In 19 (16%) of 117 patients with severe COVID-19 treated on our ICU EBV reactivations were identified, comparable 18 (14%) of 126 in the non-COVID-19 control group (P=.672). Similarly, in 11 (9%) of 117 patients CMV reactivations were identified, comparable to the 16 (13%) of 126 in the non-COVID-19 sepsis patients (P=.296). The majority of EBV (58%) and CMV reactivations (55%) were detected in patients under systemic corticosteroid treatment. 7 (37%) of 19 patients with EBV reactivation survived the ICU stay, 2 (29%) of 7 patients with rituximab treatment and 5 (42%) of 12 patients without treatment (P=.568). Five (50%) of 10 patients with CMV reactivation survived the ICU stay, 5 (83%) of 6 patients with ganciclovir treatment and 0 of 4 patients without treatment (P=.048). Follow-up analysis in these patients showed that the initiation of treatment lead to decrease in viral load. Conclusion: Critically ill patients with COVID-19 are at a high risk for EBV and CMV reactivations. Whether these reactivations are a cause of hyperinflammation and require targeted treatment remains uncertain. However, in patients with clinical deterioration or signs of hyperinflammation targeted treatment might be beneficial and warrants further studying. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Clinical Course and Outcome of Patients with SARS-CoV-2 Alpha Variant Infection Compared to Patients with SARS-CoV-2 Wild-Type Infection Admitted to the ICU.
- Author
-
Garcia Borrega, Jorge, Naendrup, Jan-Hendrik, Heindel, Katrin, Hamacher, Laura, Heger, Eva, Di Cristanziano, Veronica, Deppe, Antje-Christin, Dusse, Fabian, Wetsch, Wolfgang Alois, Eichenauer, Dennis Alexander, Shimabukuro-Vornhagen, Alexander, Böll, Boris, and Kochanek, Matthias
- Subjects
SARS-CoV-2 ,TREATMENT effectiveness ,COVID-19 ,CRITICALLY ill patient care ,INTENSIVE care patients - Abstract
The alpha variant of the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is associated with higher transmissibility and possibly higher mortality compared with wild-type SARS-CoV-2. However, few data are available on the clinical course of infections with the alpha variant compared with wild-type SARS-CoV-2 in critically ill patients in intensive care units (ICUs). Therefore, we retrospectively analyzed patients admitted to our ICU due to SARS-CoV-2 Alpha variant infection and compared characteristics and course to patients with SARS-CoV-2 wild-type infection. The median age of patients with Alpha variant infections was 57 years compared to 62 years in the wild-type group. ICU survival was 41/80 (51%) in the Alpha variant group and 35/80 (44%) in the wild-type group (p = 0.429). Results of a matched-pair analysis based on age and sex illustrated that 45/58 patients (77.6%) in the Alpha variant group and 38/58 (65.5%) patients in the wild-type group required mechanical ventilation (p = 0.217). ICU survival was documented for 28/58 patients (48.3%) in the Alpha variant group and 27/58 patients (46.6%) in the wild-type group (p = 1). Thus, ICU mortality among patients with SARS-CoV-2 infections remains high. Although the Alpha variant group included younger patients requiring mechanical ventilation, no significant differences between patients with the SARS-CoV-2 Alpha variant and the SARS-CoV-2 wild-type, respectively, were detected with respect to clinical course and ICU mortality. For future VOCs, we believe it would be important to obtain valid and rapid data on the clinical course of critically ill patients who test positive for COVID-19 in order to perform appropriate epidemiological planning of intensive care capacity. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. Soluble CD30 receptor from Hodgkin cells stimulates granulocytes to release angiogenic interleukin-8.
- Author
-
Hansen, Hinrich Peter, Simhadri, Vijaya Lakshmi, Eichenauer, Dennis Alexander, Engert, Andreas, and Von Strandmann, Elke Pogge
- Abstract
Hodgkin lymphoma is a malignancy where the malignant Hodgkin and Reed-Sternberg (H-RS) cells typically depend on the cross-talk with normal bystander cells of the innate and adaptive immune system. CD30, a receptor of the tumor necrosis factor receptor superfamily is strongly overexpressed on H-RS cells. However, the corresponding ligand (CD153) is membrane-anchored and mainly expressed on bystander cells distant from the CD30 positive tumor cells. CD30 is released by metalloproteinase cleavage. Here, we tested whether the soluble ectodomain of CD30 (sCD30), instead of the receptor, is able to communicate with distant granulocytes. We showed that metalloproteinase-dependent CD30 shedding from H-RS cells is stimulated upon growth factor reduction and heat-shock. Soluble CD30, released in the microenvironment, is initially multimerized. This form stimulated distant granulocytes by reverse signaling to release interleukin-8 (IL-8) which is involved in angiogenesis and metastasis. This finding suggests that malignant H-RS cells might use receptor shedding not only to compete a cross-talk but also manipulate distant cells in a trans-signaling manner to generate survival factor. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
6. [Handoffs in the intensive care unit].
- Author
-
Reifarth E, Naendrup JH, Garcia Borrega J, Altenrath L, Shimabukuro-Vornhagen A, Eichenauer DA, Kochanek M, and Böll B
- Subjects
- Humans, Germany, Checklist, Interdisciplinary Communication, Medical Errors prevention & control, Patient Care Team organization & administration, Critical Care standards, Patient Handoff organization & administration, Patient Handoff standards, Intensive Care Units, Patient Safety
- Abstract
Background: Effective handoffs in the intensive care unit (ICU) are key to patient safety., Purpose: This article aims to raise awareness of the significance of structured and thorough handoffs and highlights possible challenges as well as means for improvement., Materials and Methods: Based on the available literature, the evidence regarding handoffs in ICUs is summarized and suggestions for practical implementation are derived., Results: The quality of handoffs has an impact on patient safety. At the same time, communication in the intensive care setting is particularly challenging due to the complexity of cases, a disruptive work environment, and a multitude of inter- and intraprofessional interactions. Hierarchical team structures, deficiencies in feedback and error-management culture, (technical) language barriers in communication, as well as substantial physical and psychological stress may negatively influence the effectiveness of handoffs. Sets of interventions such as the implementation of checklists, mnemonics, and communication workshops contribute to a more structured and thorough handoff process and have the potential to significantly improve patient safety., Conclusion: Effective handoffs are the cornerstone of high-quality and safe patient care but face particular challenges in ICUs. Interventional measures such as structuring handoff concepts and periodic communication trainings can help to improve handoffs and thus increase patient safety., (© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.